Acadia Pharmaceuticals will replace Independent Bank Group in S&P SmallCap 600
by
Contributor since / Followers
Contributor since / Followers
3 days ago
- Acadia Pharmaceuticals (NASDAQ:ACAD) will replace Independent Bank Group (NASDAQ:IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025.
- S&P MidCap 400 constituent SouthState (SSB) is acquiring Independent Bank Group (IBTX) in a deal expected to close soon pending final conditions.